Trade Summary

1 month ago, Gill John, serving as Dir at Altimmune, Inc. (ALT), purchased 9,200 shares at $3.41 per share, for a total transaction value of $31,350.00. Following this transaction, Gill John now holds 21,700 shares of ALT.

This purchase represents a 74.00% increase in Gill John's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Monday, April 6, 2026 and publicly disclosed via SEC Form 4 filing on Monday, April 6, 2026, meaning the disclosure happened on the same day as the trade.

Altimmune, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider buying activity in this sector can provide valuable signals about industry trends and company-specific developments.